Let’s talk about hemophilia on the occasion of this World Day, the beard of men would contain more bacteria than the coat of dogs and a new advance has been developed to block the development of Alzheimer’s disease.
World Hemophilia Day: a still little-known hereditary disease
About 7,000 people in France suffer from hemophilia, a rare hereditary genetic disease that prevents blood from clotting properly. As explained Inserm, in case of bleeding, the flow can not stop or then very difficult. “Patients therefore risk severe bleeding in the event of an injury and sometimes spontaneous bleeding, especially in the joints”. Current treatments make it possible to “control” the disease, but not to cure it. This 29th hemophilia day is an opportunity to talk about this little-known pathology, often stigmatized and misunderstood. To read our article, click here.
Men’s beards contain more bacteria than dogs’ coats
During a study on the possible transmission of diseases between dogs and humans, researchers from the Hirslanden Clinic in Switzerland found that men’s beards contained more germs and bacteria than canine coats. The researchers first took samples from the beards of 18 men between the ages of 18 and 76 and from the necks of 30 dogs of different breeds, to compare bacterial amounts. “Our study shows a significantly higher bacterial load on men’s beards than in dogs’ fur. All participants had microbial colony counts high, whereas this was the case in only 23 of the 30 dogs: 7 had indeed a moderate microbial colony count”. To read more, click here.
Alzheimer’s: a synthetic protein developed to block the development of the disease
Today, nearly 850,000 people suffer from Alzheimer’s disease in France. The milestone of two million could be reached by 2030, because the population is aging, and age is the main factor in disease. The causes of this pathology are not yet known, but we know how it manifests itself. Proteins, beta-amyloids, accumulate abnormally in the brain to form plaques and lesions later. American researchers from the University of Washington in Seattle and other research centers in the country have developed a synthetic peptide, or small protein, capable of blocking beta-amyloid and making it less harmful. The synthetic peptide folds into a structure called an alpha sheet. We tell you more in our article.
.
